Results 21 to 30 of about 4,179,804 (295)

Cervical Cancer Screening [PDF]

Journal of the National Comprehensive Cancer Network, 2010
These NCCN Guidelines Insights focus on recent recommendations for cervical cancer screening and management of abnormal screening tests. When the NCCN Panel convened to update the NCCN Guidelines for Cervical Cancer Screening, they decided to adopt and endorse guidelines from other organizations to avoid duplication of effort.
Edward E, Partridge, Nadeem R, Abu-Rustum, Susan M, Campos, Patrick J, Fahey, Michael, Farmer, Rochelle L, Garcia, Anna, Giuliano, Howard W, Jones, Subodh M, Lele, Richard W, Lieberman, Stewart L, Massad, Mark A, Morgan, R Kevin, Reynolds, Helen E, Rhodes, Diljeet K, Singh, Karen, Smith-McCune, Nelson, Teng, Cornelia Liu, Trimble, Fidel, Valea, Sharon, Wilczynski   +19 more
openaire   +2 more sources

Screening for cervical cancer

Indian Journal of Medical Research, 2021
Cervical cancer is the fourth most common cancer in women in the world. To eliminate cervical cancer by 2030, the World Health Organization has given the target of 70 per cent coverage of twice lifetime screening. A multitude of screening methods are available, including cytology, human papillomavirus (HPV) DNA testing and ...
Rajaram, Shalini, Gupta, Bindiya
openaire   +2 more sources

Economic evaluation of three populational screening strategies for cervical cancer in the county of Valles Occidental: CRICERVA clinical trial [PDF]

, 2011
Copyright @ 2011 Acera et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution ...
Bonet, JM, Trapero-Bertran, Marta, Pilar Soteras, Sanchez, Norman, Sanchez, N, Soteras, P, Prieto, Gemma, Rodriguez, A, Gemma Prieto, Hidalgo Pablo, Soteras Pilar, Prieto Gemma, Josep M Bonet, Manresa Josep M, Bonet Josep M, Rodriguez Ana, Hidalgo, Pablo, Toran Pere, Trapero-Bertran, M, Sanchez Norman, Marta Trapero-Bertran, Acera Amelia, Norman Sanchez, Josep M Manresa, Toran, P, Pere Toran, Manresa, Josep M., Pablo Hidalgo, Hidalgo, P, Trapero-Bertran Marta, Amelia Acera, Rodriguez, Ana, Ana Rodriguez, Soteras, Pilar, Toran, Pere, Acera, A, Manresa, JM, Acera, Amelia, Bonet, Josep M., Prieto, G   +39 more
core   +2 more sources

Clients' returning for cervical screening results : a focus group study exploring the reasons why women spontaneously return for their results at the Khayelitsha Cervical Cancer Screening Project [PDF]

, 2004
Bibliography: leaves 112-123.Cervical cancer is integrally associated with the problems of poverty in the developing world. It is the most common cancer cause of death among women in these regions.
Honikman, Simone
core   +1 more source

TP53 polymorphism, HPV infection, and risk of cervical cancer. [PDF]

, 2001
The role of a polymorphism at position 72 of the tumor suppressor gene TP53 in the development of cervical cancer is not well established. The arginine variant of the p53 protein could be more susceptible to degradation by human papillomavirus (HPV) E6 ...
Hainaut, P, Muñoz, N, Peixoto-Guimaraes, D, Santos, C, Guerrero, I, Almonte, M, Wilmotte, R, Lenoir, G, Caceres, E, Klug, SJ, Herrero, R, Walboomers, JM   +11 more
core   +4 more sources

Clinical relevance of the borderline results of the Hybrid Capture 2 High-Risk HPV DNA assay with cervical samples collected in Specimen Transport Medium

Radiology and Oncology, 2019
The Hybrid Capture 2 (HC2) High-Risk HPV DNA assay serves as a triage test in the Slovenian national cervical cancer screening programme ZORA. To improve the limited analytical accuracy of HC2 test results near the cut-off value (1.0 relative light units/
Varl Jerneja, Ivanus Urska, Marinsek Ziva Pohar, Jerman Tine, Valencak Anja Ostrbenk, Poljak Mario, Prevodnik Veronika Kloboves   +6 more
doaj   +1 more source

Knowledge about cervical cancer and barriers of screening program among women in Wufeng County, a high-incidence region of cervical cancer in China. [PDF]

PLoS ONE, 2013
Cervical cancer screening is an effective method for reducing the incidence and mortality of cervical cancer, but the screening attendance rate in developing countries is far from satisfactory, especially in rural areas.
Yao Jia, Shuang Li, Ru Yang, Hang Zhou, Qunying Xiang, Ting Hu, Qinghua Zhang, Zhilan Chen, Ding Ma, Ling Feng   +9 more
doaj   +1 more source

Economic modelling assessment of cervical cancer screening and HPV vaccination in Brazil [PDF]

More than 85% of the global burden of cervical cancer occurs in developing countries, where it is the second most common cancer among women. In Brazil alone, a total of 17,500 new cases and 3,300 deaths of cervical cancer are expected in 2012.
Vanni, Tazio
core   +1 more source

Factors associated with late presentation of cervical cancer cases at a district hospital: a retrospective study

BMC Public Health, 2018
Background Cervical cancer is the leading and most common female cancer among women in Ghana. Although there are screening methods to detect premalignant lesions for treatment, screening coverage in Ghana is 2.8% and late presentation of cases ...
Priscilla Dunyo, Kofi Effah, Emilia Asuquo Udofia   +2 more
doaj   +1 more source

Correction to: Factors associated with late presentation of cervical cancer cases at a district hospital: a retrospective study

BMC Public Health, 2018
It has been highlighted, that the original article [1] contained errors in Fig. 1. On the 3rd level, the first box should read “Records with any required information = 157” and the second box should read “Records without any required information = 0 ...
Priscilla Dunyo, Kofi Effah, Emilia Asuquo Udofia   +2 more
doaj   +1 more source